#+TITLE: Mucopolysaccharidoses Overview
#+AUTHOR: Matthew Henderson, PhD, FCACB
#+DATE: \today

:PROPERTIES:
#+DRAWERS: PROPERTIES
#+LaTeX_CLASS: beamer
#+LaTeX_CLASS_OPTIONS: [presentation, smaller]
#+BEAMER_THEME: Hannover
#+BEAMER_COLOR_THEME: whale
#+BEAMER_FRAME_LEVEL: 2
#+COLUMNS: %40ITEM %10BEAMER_env(Env) %9BEAMER_envargs(Env Args) %4BEAMER_col(Col) %10BEAMER_extra(Extra)
#+OPTIONS: H:2 toc:nil
#+PROPERTY: header-args:R :session *R*
#+PROPERTY: header-args :cache no
#+PROPERTY: header-args :tangle yes
#+STARTUP: beamer
#+STARTUP: overview
#+STARTUP: hidestars
#+STARTUP: indent
#+BEAMER_HEADER: \institute[NSO]{Newborn Screening Ontario | The University of Ottawa}
#+BEAMER_HEADER: \titlegraphic{\includegraphics[height=1cm,keepaspectratio]{../logos/NSO_logo.pdf}\includegraphics[height=1cm,keepaspectratio]{../logos/cheo-logo.png} \includegraphics[height=1cm,keepaspectratio]{../logos/UOlogoBW.eps}}
#+latex_header: \hypersetup{colorlinks,linkcolor=white,urlcolor=blue}
#+LaTeX_header: \usepackage{textpos}
#+LaTeX_header: \usepackage{textgreek}
#+LaTeX_header: \usepackage[version=4]{mhchem}
#+LaTeX_header: \usepackage{chemfig}
#+LaTeX_header: \usepackage{siunitx}
#+LaTeX_header: \usepackage{gensymb}
#+LaTex_HEADER: \usepackage[usenames,dvipsnames]{xcolor}
#+LaTeX_HEADER: \usepackage[T1]{fontenc}
#+LaTeX_HEADER: \usepackage{lmodern}
#+LaTeX_HEADER: \usepackage{verbatim}
#+LaTeX_HEADER: \usepackage{tikz}
#+LaTeX_HEADER: \usetikzlibrary{shapes.geometric,arrows,decorations.pathmorphing,backgrounds,positioning,fit,petri}
:END:

#+BEGIN_LaTeX

# %\logo{\includegraphics[width=1cm,height=1cm,keepaspectratio]{../logos/NSO_logo_small.pdf}~%
# %    \includegraphics[width=1cm,height=1cm,keepaspectratio]{../logos/UOlogoBW.eps}%
# }

\vspace{220pt}
\beamertemplatenavigationsymbolsempty
\setbeamertemplate{caption}[numbered]
\setbeamerfont{caption}{size=\tiny}
#  \addtobeamertemplate{frametitle}{}{%
#  \begin{textblock*}{100mm}(.85\textwidth,-1cm)
#  \includegraphics[height=1cm,width=2cm]{cat}
#  \end{textblock*}}

\tikzstyle{chemical} = [rectangle, rounded corners, text width=5em, minimum height=1em,text centered, draw=black, fill=none]
\tikzstyle{hardware} = [rectangle, rounded corners, text width=5em, minimum height=1em,text centered, draw=black, fill=gray!30]
\tikzstyle{ms} = [rectangle, rounded corners, text width=5em, minimum height=1em,text centered, draw=orange, fill=none]
\tikzstyle{msw} = [rectangle, rounded corners, text width=7em, minimum height=1em,text centered, draw=orange, fill=none]
\tikzstyle{label} = [rectangle,text width=8em, minimum height=1em, text centered, draw=none, fill=none]
\tikzstyle{hl} = [rectangle, rounded corners, text width=5em, minimum height=1em,text centered, draw=black, fill=red!30]
\tikzstyle{box} = [rectangle, rounded corners, text width=5em, minimum height=5em,text centered, draw=black, fill=none]
\tikzstyle{arrow} = [thick,->,>=stealth]
\tikzstyle{hl-arrow} = [ultra thick,->,>=stealth,draw=red]

#+END_LaTeX

* Introduction
** Proteoglycans 

#+NAME: fig:pg
#+ATTR_LaTeX: :width 0.8\textwidth
[[file:./figures/ch17f01.jpg]]

** Proteoglycans function

- Structural proteins of the ECM are embedded in gels formed from
  proteoglycans.
- Composed of glycosaminoglycans (GAGs) linked to a protien core.
- Negatively charged GAGs bind Na^{+}
  - draws water to create a gel 
- Found in interstitial connective tissues such as: 
  - synovial fluid
  - vitreous humour, cornea
  - arterial walls
  - bone, cartilage


** Proteoglycans synthesis

#+NAME: fig:synth
#+ATTR_LaTeX: :width 0.8\textwidth
[[file:./figures/ch3f1.jpg]]


** Glycosaminoglycans

1. heparin
2. heparin sulfate
3. chondroitin sulfate
4. dermatan sulfate
5. keratan sulfate
6. hyaluronan (not typically protein bound)


- GAGs are composed of repeating units of disaccharides.
  - hexosamine and a hexose or hexuronic acid

** Symbol Nomenclature for Glycans (SNFG)


#+NAME: fig:snfg
#+ATTR_LaTeX: :width 0.8\textwidth
[[file:./figures/snfg.png]]


** Glycosaminoglycans


#+NAME: fig:gags
#+ATTR_LaTeX: :width 0.8\textwidth
[[file:./figures/ch17f02.jpg]]

** GAGs

*** Hyaluronan 
- not sulfated, not protein bound
- forms in the plasma membrane instead of the Golgi
- connective, epithelial, and neural tissues.
- cell proliferation and migration

*** Chondroitin sulfate
- O-xylose-linked to core proteins
- structural component of cartilage 

*** Dermatan sulfate
- O-xylose-linked to core proteins
- skin, blood vessels, heart valves, tendons, and lungs.O
- coagulation, cardiovascular disease, carcinogenesis, infection, wound repair, and fibrosis

** GAGs

*** Heparin Sulfate
- O-xylose-linked to core proteins
- developmental processes,angiogenesis, blood coagulation, tumour metastasis.

*** Keratan sulfate
- KSI was isolated from corneal tissue and KSII from skeletal tissue
  - KSI is N-linked to specific asparagine amino acids via
    N-acetylglucosamine
  - KSII is O-linked to specific Serine or Threonine amino acids via
    N-acetyl galactosamine.
  - cornea, cartilage,bone, CNS


* Mucopolysaccharidoses

** Mucopolysaccharidoses  
- type of lysosomal storage disease
- a group of metabolic disorders caused by the absence or
  malfunctioning of lysosomal enzymes needed to break down
  glycosaminoglycans.
- can be a result of decreased expression, stability, and activity of
  one of the eleven enzymes required for glycosaminoglycans
  degradation
- GAGs collect in the cells, blood and connective tissues.
  - The result is permanent, progressive cellular damage which affects:
    - appearance
    - physical abilities
    - organ and system functioning,
    - in most cases, mental development. 

** Glycosaminoglycan degradation

#+NAME: fig:degradation
#+ATTR_LaTeX: :width 0.8\textwidth
[[file:./figures/ch16f9.jpg]]


** Mucopolysaccharidoses  

\small
| Name                    | Enzyme                   | GAG      |
|-------------------------+--------------------------+----------|
| MPS I (Hurler)          | \alpha-iduronidase       | HS,DS    |
| MPS II (Hunter)         | Iduronate-2-sulfatase    | HS,DS    |
|-------------------------+--------------------------+----------|
| MPS IIIA (Sanfilippo A) | Heparin-N-Sulfatase      | HS       |
| MPS IIIB (Sanfilippo B) | N-acetyl glucosaminidase | HS       |
| MPS IIIC (Sanfilippo C) | Acetyl CoA glucosamine   | HS       |
|                         | N-acetyltransferase      |          |
| MPS IIID (Sanfilippo D) | N-acetyl-glucosamine     | HS       |
|                         | 6-sulfatase              |          |
|-------------------------+--------------------------+----------|
| MPS IVA (Morquio A)     | N-acetylgalactosamine    | KS,CS    |
|                         | 6-sulfatase              |          |
| MPS IVB (Morquio B)     | \beta-galactosidase      | KS       |
|-------------------------+--------------------------+----------|
| MPS VI (Maroteaux-Lamy) | N-acetylgalactosamine    | DS       |
|                         | 4-sulfatase              |          |
| MPS VII (Sly)           | \beta-glucuronidase      | DS,HS,CS |
| MPS IX                  | hyaluronidase            | HA       |
| MSD (Austin)            | formylglycine-generating | HS,DS    |
|                         | enzyme                   |          |

  

** Classification
- Presenting as a dysmorphic syndrome
  - MPS I (Hurler)
  - MPS II (Hunter)
  - MPS VI (Maroteaux-Lamy)
- Presenting with learning difficulties, behavioral disturbances and dementia
  - MPS III (Sanfilippo)
- Presenting with severe bone dysplasia
  - MPS IV (Morquio)
- Others rare
  - MPS VII (Sly)
  - MPS IX (Natowicz)



** Dermatan sulfate degradation

#+NAME: fig:dse
#+ATTR_LaTeX: :width 0.6\textwidth
[[file:./figures/ds_degradation_disorders.png]]


** Keratan sulfate degradation
#+NAME: fig:kse
#+ATTR_LaTeX: :width 0.6\textwidth
[[file:./figures/ks_degradation_disorders.png]]


** Heparin degradation
#+NAME: fig:hse
#+ATTR_LaTeX: :width 0.5\textwidth
[[file:./figures/hs_degradation_disorders.png]]


** Next Up

- NBS for MPS I
